Leaflet: information for the patient
Paracetamol Stadapharm 1 g tablets EFG
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
Follow exactly the administration instructions for the medicine contained in this leaflet or those indicated by your doctor or pharmacist.
1. What is Paracetamol Stadapharm and what it is used for
2. What you need to know before starting to take Paracetamol Stadapharm
3. How to take Paracetamol Stadapharm
4. Possible side effects
5. Storage of Paracetamol Stadapharm
6. Contents of the pack and additional information
Paracetamol Stadapharm belongs to a group of medicines called analgesics and antipyretics.
It is used for the treatment of mild to moderate pain and febrile states in adults and adolescents 16 years of age or older (or with a body weight of 50 kg or more).
Do not take Paracetamol Stadapharm
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Paracetamol Stadapharm:
Inform your doctor immediately if you have any of the following during treatment with Paracetamol Stadapharm:
Paracetamol can cause severe skin reactions, such as acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal. Inform patients about the symptoms of severe skin reactions and discontinue use of the medication at the first sign of skin eruption or any other sign of hypersensitivity.
Do not take more paracetamol than recommended in section 3 “How to take Paracetamol Stadapharm”). Avoid simultaneous use of this medicine with other medicines containing paracetamol, such as cold and flu medications, as high doses may cause liver damage. Do not use more than one paracetamol-containing medication without consulting your doctor. If you experience an overdose, seek medical attention immediately (see “If you take more Paracetamol Stadapharm than you should”).
This medicine should not be used for self-medication of high fever (over 39°C), prolonged fever (over 3 days), or recurrent fever, unless your doctor prescribes it, as these situations may require medical evaluation and treatment.
Administration of paracetamol doses higher than recommended implies a high risk of severe liver damage. Medicines containing paracetamol should not be taken for more than a few days or at high doses, unless your doctor advises you to.
Prolonged use of analgesics or excessive use of high doses may cause headaches, which should not be treated with higher doses of the medication.
Interference with analytical tests:If you are to undergo any analytical test (including blood, urine, etc.) inform your doctor that you are taking this medicine, as it may alter the results. Paracetamol may alter the values of uric acid and glucose determinations.
Children and Adolescents
Consult your doctor or pharmacist for children and adolescents under 16 years old, as there may be other presentations available with doses adapted to these patients.
Other Medicines and Paracetamol Stadapharm
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Particularly, if you are using any of the following medicines, as it may be necessary to modify the dose of some of them or interrupt treatment:
Antiepileptic Medications (carbamazepine, phenytoin, phenobarbital, primidone, lamotrigine): The combination of paracetamol and antiepileptic medications may cause or worsen liver damage.
Lamotrigine: The effect of lamotrigine may be reduced.
Medications for High Blood Pressure and Heart Rhythm Disorders (propranolol): The combination of paracetamol and propranolol may increase the effect and/or toxicity.
Medications for Gout (probenecid): Causes a reduction of almost twice in the excretion of paracetamol. Consider reducing the paracetamol dose when administering a concomitant treatment with probenecid.
Medications for Tuberculosis (rifampicin, isoniazid): The combination of paracetamol and rifampicin or isoniazid may cause or worsen liver damage.
Salicylamide, a medication for fever and pain: May prolong the elimination half-life (t1/2) of paracetamol.
Medications to Lower Cholesterol in the Blood (colestiramine): Reduces the absorption of paracetamol. To avoid this, paracetamol should be administered one hour before or 4 hours after the resin.
Medications to Prevent Nausea and Vomiting (metoclopramide and domperidone): Simultaneous ingestion of medications that cause accelerated gastric emptying, such as metoclopramide and domperidone, increases the absorption and anticipates the onset of paracetamol action. However, it is not necessary to avoid concomitant use.
Anticoagulant Medications (oral anticoagulants such as acenocoumarol, warfarin): Paracetamol may increase the effects of oral anticoagulants. Prolonged use of this medicine in patients treated with oral anticoagulants should only be done under medical supervision. A potentiation of warfarin effects has been observed with high-dose, continued paracetamol.
Diuretics (furosemide): The effects of diuretics may be reduced.
Chloramphenicol, an antibiotic medication: Simultaneous administration of paracetamol and chloramphenicol may significantly delay the excretion of chloramphenicol, increasing its plasma concentrations and causing a higher risk of toxicity.
Zidovudine (AZT), a medication used in viral diseases: Concomitant administration of paracetamol and AZT may increase the incidence of neutropenia or worsen it (reduction of white blood cell count). Paracetamol should only be taken simultaneously with AZT if your doctor recommends it.
Concomitant use of substances that induce hepatic enzymes, such as barbiturates, carbamazepine, isoniazid, rifampicin, or ethanol, should be taken into account, as they may potentiate the toxic effect of paracetamol.
Inform your doctor if this medicine is taken with medications that delay gastric emptying (e.g., propantelina) or that accelerate gastric emptying (e.g., metoclopramide and domperidone).
Flucloxacillin (antibiotic), due to a high risk of blood and fluid imbalance (metabolic acidosis with high anion gap) that must be treated urgently (see section 2).
Paracetamol Stadapharm and Alcohol
Do not take alcohol during treatment with paracetamol.
Pregnancy and Breastfeeding
Consult your doctor or pharmacist if you are pregnant, breastfeeding, think you may be pregnant, or intend to become pregnant before using this medicine.
Pregnancy
Paracetamol can be used during pregnancy if necessary. Use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor or midwife if pain or fever do not decrease or if you need to take the medication more frequently.
Breastfeeding
Paracetamol passes into breast milk. Therapeutic doses of paracetamol can be administered during breastfeeding.
Driving and Operating Machines
The influence of paracetamol on the ability to drive and operate machines is negligible or insignificant. However, during treatment with paracetamol, you may experience mild drowsiness and dizziness.
Paracetamol Stadapharm contains Sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially “sodium-free”.
The recommended dose is:
Adults and adolescents over 16 years (or weight over 50 kg):
The usual dose is one tablet (1 g of paracetamol) 3 times a day. The doses should be spaced at least 4 hours apart. Do not take more than 3 grams (3 tablets) in 24 hours.
The tablet can be divided into equal doses.
It is recommended to avoid high daily doses of paracetamol for prolonged periods of time, as this increases the risk of adverse effects such as liver damage.
If the pain persists for more than 5 days, the fever for more than 3 days, or if the pain or fever worsen or other symptoms appear, you should interrupt treatment and consult your doctor.
Patients with liver disease:Before taking this medication, you must consult your doctor. You should take the amount of medication prescribed by your doctor with a minimum interval of 8 hours between each dose. Do not take more than 2 grams of paracetamol in 24 hours, divided into two doses. In chronic alcoholics, do not exceed a dose of 2 g per day.
Patients with kidney disease:Before taking this medication, you must consult your doctor. Take a maximum of 500 mg per dose. Due to the dose, 1 g of paracetamol is not indicated for this group of patients.
Older patients: you should consult your doctor.
Use in children and adolescents
This medication is not recommended for use in children and adolescents under 16 years or weight less than 50 kg.
If it is estimated that the action of paracetamol is too strong or too weak, inform your doctor or pharmacist. When requiring the administration of doses lower than 1 g of paracetamol per dose, other presentations of paracetamol should be used that adapt to the required dosage.
If you takemore Paracetamol Stadapharm than you should
You should consult your doctor or pharmacist immediately.
The symptoms of overdose may be: dizziness, vomiting, loss of appetite, yellowish discoloration of the skin and eyes (jaundice) and abdominal pain.
If you have ingested an overdose, you should go immediately to a medical center, even if you do not notice the symptoms, as these often do not manifest until 3 days after ingestion of the overdose, even in cases of severe intoxication.
The treatment of overdose is more effective if it is initiated within 4 hours of ingestion of the medication.
Patients undergoing barbiturate treatment or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicological Information Service, phone 915 620 420, indicating the medication and the amount ingested.
If you forgot to take Paracetamol Stadapharm
Do not take a double dose to compensate for the missed doses, simply take the missed dose when you remember, taking the next doses with the indicated spacing between doses (at least 4 hours).
The following adverse effects have been reported in patients treated with paracetamol:
Rare(may affect up to 1 in 1,000 people):
Very Rare(may affect up to 1 in 10,000 people):
Unknown Frequency(cannot be estimated from available data):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctororfarmacist, even if it is possible adverse effects that do not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.esBy reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Paracetamol Stadapharm
Appearance of the product and contents of the packaging
White or almost white tablets, in capsule form with a scored line marked on one face with “10” and “00” on either side of the scored line and on the other face with “PA” and “RA” on either side of the scored line. The tablet can be divided into equal doses.
Paracetamol Stadapharm is available in blisters containing 10 tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
STADA Laboratory, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Responsible for manufacturing
Qualimetrix S.A.
579 Mesogeion Avenue, Agia Paraskevi,
Athens, 15343
Greece
Last review date of this leaflet:January 2025
The detailed information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.